Sort
40,608 grants matching “prostate cancer”
SDF-1 mRNA gene therapy for restoration of erectile function
$314,913Nikolai Anton Sopko · Evincis Bio, Inc. · R43 · FY2021 · DK
Targeting aggressive prostate cancer with novel theranostic nanomedicine
$314,875Jer-Tsong Hsieh · Ut Southwestern Medical Center · R01 · FY2014 · CA
Hypoxia and Gene Repression
$314,835Amato J. Giaccia · Stanford University · R37 · FY2014 · CA
Tyrosine Kinases and Prostate Cancer
$314,832Hsing-Jien Kung · University Of California At Davis · R01 · FY2008 · DK
Tyrosine Kinases and Prostate Cancer
$314,832Hsing-Jien Kung · University Of California At Davis · R01 · FY2009 · DK
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
$314,819Dawn Hershman · Columbia University Health Sciences · R01 · FY2014 · CA
THE ROLE OF WNT/BETA-CATENIN IN THE PROGRESSION OF CASTRATION RESISTANCE OF PROSTATE CANCER IN BONE
$314,817The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2018 · Defense Health Agency
Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer
$314,812Giovanni Parmigiani · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Equol and Regulation of Prostate Growth
$314,811Robert J Handa · University Of Arizona · R01 · FY2009 · CA
MS/AL Radiation Oncology Research Partnership
$314,642James E. Clarkson · Singing River Health System · U54 · FY2012 · CA
MnTE-2-PyP as a radioprotector in prostate cancer therapy
$314,612Rebecca E Oberley-Deegan · University Of Nebraska Medical Center · R01 · FY2016 · CA
MnTE-2-PyP as a radioprotector in prostate cancer therapy
$314,612Rebecca E Oberley-Deegan · University Of Nebraska Medical Center · R01 · FY2017 · CA
MnTE-2-PyP as a radioprotector in prostate cancer therapy
$314,612Rebecca E Oberley-Deegan · University Of Nebraska Medical Center · R01 · FY2018 · CA
Palliative Care for Cancer Patients in Emergency Wards
$314,604Linda Leah Emanuel · Northwestern University At Chicago · R25 · FY2007 · CA
Palliative Care for Cancer Patients in Emergency Wards
$314,604Linda Leah Emanuel · Northwestern University At Chicago · R25 · FY2009 · CA
The Induction of Gene-specific RNAi Against Cancer-associated Genes
$314,559Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Prostate carcinogenesis and PKC signaling
$314,528University Of Pennsylvania · R01 · FY2004 · CA
Integrative Metabolomics of Prostate Cancer Progression
$314,511Arun Sreekumar · Baylor College Of Medicine · R01 · FY2012 · CA
Prostate carcinogenesis and PKC signaling
$314,450Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2009 · CA
AD OC TK/VAL GENE THERAPY CLINICAL CORRELATES
$314,443Emory University · R21 · FY2001 · CA
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
$314,393Arun Sreekumar · Baylor College Of Medicine · U01 · FY2014 · CA
Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL
$314,365Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2017 · CA
Preventive Analgesia for Bone Cancer Pain
$314,363Patrick W Mantyh · University Of Arizona · R01 · FY2011 · CA
Preventive Analgesia for Bone Cancer Pain
$314,363Patrick W Mantyh · University Of Arizona · R01 · FY2012 · CA
Molecular determinant of racial disparity in prostate cancer
$314,363Ajay Pratap Singh · University Of South Alabama · U01 · FY2018 · CA